Antibiotic Prophylaxis for Transrectal Prostate Biopsy-Ciprofloxacin vs. Trimethoprim/Sulfamethoxazole
Status:
Unknown status
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
This study will examine if a single dose of Ciprofloxacin and Trimethoprim/Sulfamethoxazole
are equivalent for prophylaxis immediately prior to prostate biopsy, when a patient has a
suspected prostate cancer.